Comorbidities and Prescribed Medications in Korean Patients with Chronic Hepatitis C: A Nationwide, Population-Based Study
Author:
Affiliation:
1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
2. National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea
Funder
Gilead Foundation
Korea Centers for Disease Control and Prevention
Publisher
The Editorial Office of Gut and Liver
Subject
Gastroenterology,Hepatology
Link
http://pdf.medrang.co.kr/GNL/2021/015/GNL015-02-15.pdf
Reference14 articles.
1. Cardiovascular Risk Management and Hepatitis C: Combining Drugs
2. The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug‐drug interactions
3. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C
4. Liver disease selectively modulates cytochrome P450–mediated metabolism
5. Tamoxifen-induced hepatotoxicity caused by drug interaction with direct-acting antiviral agents for hepatitis C
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The association between hepatitis C virus infection status and blood pressure in adults in the United States: NHANES 1999–2012;Frontiers in Cellular and Infection Microbiology;2024-06-04
2. Effects of comorbid conditions and prescribed chronic medications on the treatment plan for chronic hepatitis C infection: A cross‐sectional retrospective study;Health Science Reports;2024-04-29
3. Cross-Sectional Analysis of Chronic Hepatitis B Complicated with Diseases;Hans Journal of Biomedicine;2024
4. Cross-Sectional Analysis and DDI Study of Drugs Used for Hepatitis C combined with Disease in a Hospital in Yunnan Province;Advances in Microbiology;2024
5. Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study;The Korean Journal of Internal Medicine;2023-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3